Effect of Addition of Clopidogrel to Aspirin on Subdural Hematoma: Meta-Analysis of Randomized Clinical Trials

Abstract

Background

Clopidogrel combined with aspirin is routinely prescribed after coronary artery stenting, in patients with acute coronary syndromes, and recently to prevent stroke in patients with acute minor ischemic stroke and TIA. Subdural hematomas are an important complication of antithrombotic treatment, but the risk associated with clopidogrel plus aspirin has not been previously defined.

Purpose

To quantify the risk of subdural hematoma associated with dual antiplatelet therapy with clopidogrel plus aspirin.

Methods

Randomized clinical trials comparing clopidogrel plus aspirin with aspirin alone were identified by searching the Cochrane Central Register of Controlled Trials from 1990 to 2014, and restricted to those with more than 7 days of treatment. Two reviewers independently extracted data about subdural hematomas.

Results

Of 24 randomized trials testing clopidogrel added to aspirin, results for subdural hematoma were available for 11 trials, of which eight did not identify any subdural hematomas. The three trials reporting subdural hematomas were double-blind and included patients with recent lacunar stroke, acute coronary syndromes or atrial fibrillation with a total of 23,136 patients (mean age 66 years) and reported 39 subdural hematomas during a mean follow-up 2·1 years per patient. Clopidogrel plus aspirin was associated with a significantly increased risk of subdural hematoma compared with aspirin alone (risk ratio 2·0, 95% CI 1·0, 3·8; P = 0·04; fixed effects model; I² for heterogeneity of 0%, P = 0·51). The average absolute incidence of subdural hematoma averaged 1·1 (95%CI 0·7,1·6) per 1000 patient – years among those assigned clopidogrel plus aspirin in 11 randomized trials.

Conclusions

The absolute rate of subdural hematoma during dual antiplatelet therapy is low, averaging 1·1 per 1000 patient-years. Chronic treatment with clopidogrel plus aspirin significantly increases the risk of subdural hematoma compared with aspirin alone.

Keywords

antiplatelet therapy aspirin meta-analysis clopidogrel subdural hematoma

Get full access to this article

View all access options for this article.

References

Fang

Chang

. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 2007; 120:700–5.

Hart

Diener

H-C

Yang

. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke 2012; 43:1511–7.

Singer

Chang

Fang

. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation? The ATRIA Study. Circ Cardiovasc Qual Outcomes 2009; 2:297–304.

Eikelboom

Connolly

Hart

. Balancing the benefits and risks of two doses of dabigatran compared with warfarin in atrial fibrillation. J Am Coll Cardiol 2013; 62:900–8.

Connolly

Eikelboom

. Weighted net clinical benefit of addition of clopidogrel to aspirin in patients with atrial fibrillation unsuitable for a vitamin K antagonist. Ann Intern Med 2011; 155:579–86.

Connolly

Pearce

Kurth

Kase

Hart

. Aspirin therapy and risk of subdural hematoma: meta-analysis of randomized clinical trials. J Stroke Cerebrovasc Dis 2013; 22:444–8.

Connolly

Pearce

Hart

. Vitamin K antagonists and risk of subdural hematoma: meta-analysis of randomized clinical trials. Stroke 2014; 45:1672–8.

Wang

Zhao

. for the CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013; 369:11–9.

Johnston

Easton

Farrant

. Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke 2013; 8:479–83.

10.

Palacio

Hart

Pearce

. Effect of addition of clopidogrel to aspirin on stroke incidence: meta-analysis of randomized trials. Int J Stroke 2013; doi 10.1111/ijs.12050.

11.

Squizzato

Keller

Romualdi

Middledorp

. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease (review). Cochrane Libr 2007; 3.

12.

Gouya

Arrich

Wolzi

. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular disease. A systematic review and meta-analysis. Stroke 2014; 45:492–503.

13.

Jadad

Moore

Carroll

. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1–12.

14.

Sweeting

Sutton

Lambert

. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004; 23:1351–75. Erratum in Stat Med 2006; 25:2700.

15.

SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367:817–25.

16.

Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345:494–502.

17.

Connolly

Pogue

Hart

. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009; 360:2066–78.

18.

Cassar

Ford

Greaves

Bachoo

Brittenden

. Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty. Brit J Surg 2005; 92:159–65.

19.

Kennedy

Hill

Ryckborst

Eliasziw

Demchuck

Buchan

, for the FASTER investigators. Fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol 2007; 6:961–9.

20.

Willerson

Cable

Yeh

, on behalf of the PROCLAIM investigators. Pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose Aspirin (PROCLAIM). Tex Heart Inst J 2009; 36:530–9.

21.

Tepe

Bantleon

Brechtel

. Management of peripheral arterial intervention with mono or dual antiplatelet therapy – the MIRROR study: a randomized and double-blinded clinical trial. Eur Radiol 2012; 22:1998–2006.

22.

Steinhubl

Berger

Mann

III , CREDO Investigators. Early and sustained dual oral anti- platelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288:2411–20.

23.

Chen

Jiang

Chen

. Addition of clopidgrel to aspirin in 45852 patients with acute myocardial infarction: randomized placebo-controlled trial (COMMIT). Lancet 2005; 366:1607–21.

24.

Kulik

Le May

Voisine

. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting. Clopidogrel After Surgery for Coronary Artery Disease (CASCADE). Trial Circ 2010; 122:2680–7.

25.

Gao

Zheng

. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery. J Am Coll Cardiol 2010; 56:1639–43.

26.

ACTIVE Writing Group on behalf of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomized controlled trial. Lancet 2006; 367:1903–12.